Complete Filing Data
Nuveen Churchill Direct Lending Corp. reported Proceeds From Issuance Of Common Stock of $0.00 for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Nuveen Churchill Direct Lending Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Other General And Administrative Expense | $2.1M | $1.1M | $751.0K | $684.0K | $324.0K |
| Net Income Loss | $65.6M | $116.3M | $75.9M | $17.3M | $27.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other General And Administrative Expense | $569.0K | $411.0K | $342.0K | $145.0K | $466.0K | $277.0K | $125.0K | $357.0K | $171.0K | $332.0K | $254.0K | $59.0K |
| Net Income Loss | $18.7M | $16.0M | $15.0M | $36.6M | $20.2M | $30.0M | $20.1M | $14.3M | $12.7M | $6.0M | -$2.7M | $6.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $875.2M | $970.3M | $747.9M | $525.0M | $374.1M | $157.6M | $66.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $62.5M | $43.3M | $67.4M | $39.3M | $35.2M | $12.7M | |
| Stockholders Equity Period Increase Decrease | -$95.1M | $222.4M | $222.9M | $150.9M | $216.4M | ||
| Interest And Debt Expense | $77.9M | $79.9M | $61.2M | $25.7M | $9.8M | ||
| Dividend Income Operating Paid In Cash | $402.0K | $614.0K | $101.0K | $225.0K | $213.0K | ||
| Restricted Cash And Cash Equivalents At Carrying Value | $0.00 | $50.0K | $50.0K | $50.0K | $50.0K | ||
| Debt And Equity Securities Unrealized Gain Loss | -$21.6M | $7.3M | $714.0K | -$27.9M | $6.2M | ||
| Debt And Equity Securities Realized Gain Loss | -$6.0M | -$13.2M | -$8.0M | -$262.0K | $819.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $19.2M | -$24.1M | $28.1M | $4.1M | $22.6M | ||
| Accretion Amortization Of Discounts And Premiums Investments | $4.2M | $3.7M | $2.7M | $1.8M | $1.0M | ||
| Retained Earnings Accumulated Deficit | -$55.7M | -$26.5M | -$29.2M | -$23.9M | |||
| Cash And Cash Equivalents At Carrying Value | $67.4M | $39.3M | $35.2M | ||||
| Secured Debt | $1.12B | $1.11B | $943.9M | $699.8M | |||
| Restricted Cash | $0.00 | $50.0K | $50.0K | $50.0K | |||
| Receivable Investment Sale | $518.0K | $1.0M | $3.9M | $719.0K | |||
| Payable Investment Purchase | $0.00 | $15.0M | $0.00 | $56.0K | |||
| Management Fee Payable | $5.0M | $4.0M | $3.0M | $2.2M | |||
| Liabilities And Stockholders Equity | $2.05B | $2.14B | $1.73B | $1.25B | |||
| Liabilities | $1.18B | $1.17B | $983.0M | $729.0M | |||
| Investment Owned Percent Of Net Assets Amount | $875.2M | $970.3M | $747.9M | $525.0M | |||
| Interest Receivable | $13.7M | $18.0M | $17.7M | $11.9M | |||
| Interest Payable Current And Noncurrent | $15.4M | $13.0M | $9.8M | $8.8M | |||
| Distribution Payable | $22.2M | $29.5M | $22.7M | $14.3M | |||
| Directors Fees Payable | $156.0K | $128.0K | $96.0K | $96.0K | |||
| Deferred Finance Costs Net | $8.5M | $6.7M | $7.9M | $5.7M | |||
| Common Stock Value | $494.0K | $534.0K | $412.0K | $287.0K | |||
| Assets | $2.05B | $2.14B | $1.73B | $1.25B | |||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $3.9M | $3.7M | $2.8M | $2.6M | |||
| Investment Owned Percent Of Net Assets | $2.24 | $2.28 | $2.32 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $881.5M | $887.7M | $920.0M | $990.6M | $986.4M | $998.2M | $639.0M | $557.5M | $517.5M | $470.8M | $425.8M | $402.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $46.3M | $44.0M | $49.2M | $69.4M | $71.0M | $64.2M | $36.0M | $45.5M | $49.6M | $37.6M | $33.0M | $23.4M | |
| Stockholders Equity Period Increase Decrease | -$6.3M | -$32.3M | -$50.3M | $4.2M | -$11.9M | $250.3M | $81.5M | $40.0M | -$7.4M | $45.0M | $23.1M | $28.6M | |
| Interest And Debt Expense | $19.2M | $20.1M | $20.6M | $23.2M | $18.7M | $16.9M | $16.0M | $14.3M | $12.7M | $7.3M | $4.2M | $3.0M | |
| Dividend Income Operating Paid In Cash | $286.0K | $116.0K | $0.00 | $16.0K | $33.0K | $308.0K | $16.0K | $24.0K | $16.0K | $130.0K | $0.00 | $0.00 | |
| Restricted Cash And Cash Equivalents At Carrying Value | $0.00 | $0.00 | $0.00 | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | |
| Debt And Equity Securities Unrealized Gain Loss | -$13.6M | $4.1M | -$11.1M | -$2.4M | |||||||||
| Debt And Equity Securities Realized Gain Loss | $1.1M | -$3.6M | $6.5M | $36.0K | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $5.9M | -$3.2M | $10.3M | -$11.8M | |||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.6M | $1.0M | $905.0K | $518.0K | |||||||||
| Retained Earnings Accumulated Deficit | -$49.6M | -$46.0M | -$39.7M | -$27.2M | -$33.8M | -$23.9M | -$35.3M | -$35.9M | -$33.1M | ||||
| Cash And Cash Equivalents At Carrying Value | $44.0M | $49.2M | $43.3M | $69.3M | $71.0M | $64.1M | $36.0M | $45.4M | $49.6M | $37.5M | $33.0M | $23.3M | |
| Secured Debt | $1.11B | $1.11B | $1.20B | $1.09B | $1.02B | $817.2M | $860.2M | $818.6M | $763.7M | ||||
| Restricted Cash | $0.00 | $0.00 | $0.00 | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | ||||
| Receivable Investment Sale | $585.0K | $943.0K | $16.6M | $5.7M | $2.7M | $422.0K | $5.1M | $766.0K | $621.0K | ||||
| Payable Investment Purchase | $0.00 | $99.0K | $6.7M | $2.5M | $17.8M | $16.9M | $0.00 | $0.00 | $56.0K | ||||
| Management Fee Payable | $5.1M | $5.2M | $3.9M | $3.9M | $3.6M | $3.3M | $2.7M | $2.5M | $2.3M | ||||
| Liabilities And Stockholders Equity | $2.04B | $2.07B | $2.17B | $2.14B | $2.08B | $1.88B | $1.54B | $1.41B | $1.32B | ||||
| Liabilities | $1.16B | $1.19B | $1.25B | $1.15B | $1.10B | $877.3M | $899.7M | $853.6M | $802.9M | ||||
| Investment Owned Percent Of Net Assets Amount | $881.5M | $887.7M | $920.0M | $990.6M | $986.4M | $998.2M | $639.0M | $557.5M | $517.5M | ||||
| Interest Receivable | $16.1M | $17.2M | $20.7M | $18.1M | $18.3M | $16.1M | $15.8M | $13.1M | $11.9M | ||||
| Interest Payable Current And Noncurrent | $11.0M | $20.1M | $10.4M | $15.5M | $21.3M | $11.0M | $12.6M | $11.3M | $10.2M | ||||
| Distribution Payable | $22.2M | $22.3M | $28.3M | $30.0M | $30.1M | $24.7M | $19.6M | $17.1M | $21.8M | ||||
| Directors Fees Payable | $156.0K | $156.0K | $156.0K | $128.0K | $127.0K | $128.0K | $96.0K | $96.0K | $96.0K | ||||
| Deferred Finance Costs Net | $9.1M | $9.7M | $10.3M | $7.5M | $8.0M | $8.3M | $6.4M | $6.9M | $5.2M | ||||
| Common Stock Value | $494.0K | $495.0K | $512.0K | $546.0K | $547.0K | $548.0K | $356.0K | $311.0K | $287.0K | ||||
| Assets | $2.04B | $2.07B | $2.17B | $2.14B | $2.08B | $1.88B | $1.54B | $1.41B | $1.32B | ||||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $3.1M | $2.5M | $3.6M | $3.0M | $2.9M | $4.1M | $3.6M | $2.9M | $3.8M | ||||
| Investment Owned Percent Of Net Assets | $2.28 | $2.29 | $2.31 | $2.19 | $2.13 | $2.09 | $1.85 | $2.37 | $2.49 | $2.52 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $0.00 | $241.7M | $142.4M | $174.6M | $209.2M | $35.0M | $66.2M |
| Proceeds From Expense Support Agreement | $0.00 | $0.00 | $158.0K | $179.0K | $522.0K | ||
| Proceeds From Disposition Of Investment Operating Activity | $456.2M | $430.0M | $146.4M | $49.3M | $181.1M | ||
| Payments Of Dividends Common Stock | $102.3M | $95.2M | $63.2M | $34.7M | $14.7M | ||
| Payments For Purchase Of Investment Operating Activity | $350.7M | $863.6M | $589.0M | $502.3M | $610.7M | ||
| Net Cash Provided By Used In Operating Activities | $194.2M | -$297.2M | -$369.5M | -$427.8M | -$389.1M | ||
| Net Cash Provided By Used In Financing Activities | -$175.0M | $273.1M | $397.7M | $431.9M | $411.7M | ||
| Increase Decrease In Receivable For Investment Sold | -$506.0K | -$2.9M | $3.2M | -$4.5M | $4.3M | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $0.00 | $34.0K | -$28.0K | -$23.0K | $26.0K | ||
| Increase Decrease In Payable For Investment Purchased | -$15.0M | $15.0M | -$56.0K | -$25.7M | $25.7M | ||
| Increase Decrease In Management Fee Payable | $1.1M | $950.0K | $795.0K | $835.0K | $848.0K | ||
| Increase Decrease In Interest Payable Net | $2.4M | $3.1M | $1.0M | $6.7M | $797.0K | ||
| Increase Decrease In Due To Affiliates | $0.00 | -$632.0K | -$515.0K | -$1.5M | $248.0K | ||
| Increase Decrease In Accrued Interest Receivable Net | -$4.2M | $297.0K | $5.8M | $7.2M | $2.7M | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $248.0K | $863.0K | $206.0K | $1.7M | $38.0K | ||
| Payments Of Debt Issuance Costs | $5.6M | $2.9M | $4.5M | $3.4M | $664.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $0.00 | $241.7M | $473.0K | $30.0M | ||||||
| Proceeds From Expense Support Agreement | $0.00 | $0.00 | $0.00 | $0.00 | $144.0K | $14.0K | $55.0K | $43.0K | $51.0K | |
| Proceeds From Disposition Of Investment Operating Activity | $148.4M | $54.9M | $39.6M | $5.5M | ||||||
| Payments Of Dividends Common Stock | $29.5M | $19.3M | $12.6M | $7.2M | ||||||
| Payments For Purchase Of Investment Operating Activity | $153.0M | $204.3M | $99.9M | $62.4M | ||||||
| Net Cash Provided By Used In Operating Activities | -$8.8M | -$97.6M | -$41.1M | -$69.4M | ||||||
| Net Cash Provided By Used In Financing Activities | $14.7M | $94.3M | $51.4M | $57.6M | ||||||
| Increase Decrease In Receivable For Investment Sold | $15.5M | -$3.5M | -$98.0K | $13.5M | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $0.00 | $105.0K | $85.0K | $57.0K | ||||||
| Increase Decrease In Payable For Investment Purchased | -$8.3M | $16.9M | $0.00 | -$6.6M | ||||||
| Increase Decrease In Management Fee Payable | -$42.0K | $258.0K | $95.0K | $144.0K | ||||||
| Increase Decrease In Interest Payable Net | -$2.6M | $1.2M | $1.3M | $176.0K | ||||||
| Increase Decrease In Due To Affiliates | $0.00 | -$632.0K | -$182.0K | $71.0K | ||||||
| Increase Decrease In Accrued Interest Receivable Net | $2.7M | -$1.6M | $2.0K | $1.4M | ||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$60.0K | $1.3M | $1.2M | $226.0K | ||||||
| Payments Of Debt Issuance Costs | $5.6M | $1.6M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Issued | 49.4M | 53.4M | 41.2M | 28.7M | ||||
| Net Asset Value Per Share | $17.72 | $18.18 | $18.13 | $18.32 | $19.39 | $18.74 | $20.00 | $19.48 |
| Common Stock Shares Outstanding | 49.4M | 53.4M | 41.2M | 28.7M | 19.3M | 8.4M | 3.3M | |
| Weighted Average Number Of Shares Outstanding Basic | 50.3M | 54.1M | 33.4M | 23.3M | 12.85B | |||
| Weighted Average Number Of Diluted Shares Outstanding | 50.3M | 54.1M | 33.4M | 23.3M | 12.85B | |||
| Investment Company Net Asset Value Per Share Period Increase Decrease | $1.30 | $2.15 | $2.27 | $0.74 | $2.12 | |||
| Earnings Per Share Diluted | $1.86 | $2.26 | $2.52 | $1.95 | $1.58 | |||
| Earnings Per Share Basic | $1.86 | $2.26 | $2.52 | $1.95 | $1.58 | |||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Issued | 49.4M | 49.5M | 51.2M | 54.6M | 54.7M | 54.8M | 35.6M | 31.1M | 28.7M | 2.7M | 1.8M | 1.5M | 1.5M | 2.6M | 1.0M | 785.8K | 1.9M | 1.1M | 1.1M | 3.3M |
| Net Asset Value Per Share | $17.85 | $17.92 | $17.96 | $18.15 | $18.03 | $18.21 | $17.96 | $17.93 | $18.01 | $18.54 | $18.76 | $19.31 | ||||||||
| Common Stock Shares Outstanding | 49.4M | 49.5M | 51.2M | 54.6M | 54.7M | 54.8M | 35.6M | 31.1M | 28.7M | 25.4M | 22.7M | 20.9M | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 49.4M | 50.2M | 52.2M | 54.7M | 54.8M | 52.8M | 34.8M | 30.6M | 28.73B | 24.49B | 22.21B | 20.51B | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 49.4M | 50.2M | 52.2M | 54.7M | 54.8M | 52.8M | 34.8M | 30.6M | 28.73B | 24.49B | 22.21B | 20.51B | ||||||||
| Investment Company Net Asset Value Per Share Period Increase Decrease | $0.38 | $0.32 | $0.29 | $0.67 | $0.37 | $0.57 | $0.58 | $0.47 | $0.44 | $0.24 | $-0.12 | $0.33 | ||||||||
| Earnings Per Share Diluted | $0.43 | $0.46 | $0.53 | $0.58 | $0.57 | $0.56 | $0.62 | $0.61 | $0.62 | $0.51 | $0.44 | $0.44 | ||||||||
| Earnings Per Share Basic | $0.43 | $0.46 | $0.53 | $0.58 | $0.57 | $0.56 | $0.62 | $0.61 | $0.62 | $0.51 | $0.44 | $0.44 | ||||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | |||||||||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$21.7M | $7.1M | -$116.0K | -$27.9M | $6.2M |
| Stock Issued During Period Value New Issues | $0.00 | $241.7M | $218.5M | $175.0M | $209.1M |
| Stock Issued During Period Value Dividend Reinvestment Plan | $0.00 | $12.3M | $9.7M | $3.2M | $324.0K |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$6.0M | -$13.2M | -$8.0M | -$262.0K | $819.0K |
| Professional Fees | $3.1M | $3.1M | $3.5M | $1.8M | $1.3M |
| Other Income | $1.7M | $2.0M | $1.1M | $1.6M | $1.1M |
| Management Fee Expense | $19.3M | $14.7M | $10.5M | $7.5M | $4.0M |
| Investment Income Operating After Expense And Tax | $93.3M | $122.4M | $84.0M | $45.5M | $20.3M |
| Investment Income Investment Expense | $116.6M | $118.5M | $77.9M | $37.1M | $16.6M |
| Investment Company Net Expenses After Expense Support | $114.3M | $101.1M | $77.7M | $37.0M | $16.0M |
| Investment Company Increase Decrease From Share Transaction | -$65.7M | $220.4M | $228.2M | $178.2M | $209.5M |
| Investment Company Dividend Distribution Increase Decrease | $95.0M | $114.3M | $81.2M | $44.6M | $20.3M |
| Investment Company Dividend Distribution | $95.0M | $114.3M | $81.2M | $44.6M | $20.3M |
| Interest Income Operating Paid In Kind | $9.9M | $8.3M | $3.6M | $789.0K | $113.0K |
| Directors Fees | $624.0K | $510.0K | $383.0K | $383.0K | $383.0K |
| Administrative Fees Expense | $2.3M | $1.9M | $1.6M | $1.1M | $660.0K |
| Stock Issued1 | $0.00 | $12.3M | $9.7M | $3.2M | $324.0K |
| Paid In Kind Interest Noncash | $9.9M | $8.3M | $3.3M | $789.0K | $112.0K |
| Interest Paid Net | $71.8M | $72.6M | $58.0M | $17.5M | $9.7M |
| Amortization Of Financing Costs | $4.2M | $2.2M | $1.4M | $889.0K | |
| Stock Repurchased During Period Value | $65.7M | $33.5M | $0.00 | $0.00 | |
| Additional Paid In Capital | $930.4M | $996.3M | $776.7M | $548.6M | |
| Investment Owned At Fair Value | $1.96B | $1.71B | $1.22B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$4.2M | $3.9M | -$13.5M | $4.1M | -$11.8M | $3.9M | $11.6M | -$4.6M | -$11.5M | -$5.9M | -$12.5M | -$2.4M | |
| Stock Issued During Period Value New Issues | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $241.7M | $78.6M | $40.0M | $0.00 | $50.1M | $34.9M | $30.0M | |
| Stock Issued During Period Value Dividend Reinvestment Plan | $0.00 | $0.00 | $0.00 | $3.6M | $3.2M | $3.3M | $2.3M | $2.8M | $1.7M | $876.0K | $627.0K | $443.0K | |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $1.5M | -$10.7M | $1.1M | $1.1M | $1.0M | -$3.6M | -$13.1M | $218.0K | $6.5M | -$501.0K | $56.0K | $36.0K | |
| Professional Fees | $709.0K | $1.1M | $493.0K | $912.0K | $693.0K | $710.0K | $730.0K | $964.0K | $590.0K | $296.0K | $264.0K | $181.0K | |
| Other Income | $224.0K | $539.0K | $375.0K | $444.0K | $509.0K | $217.0K | $409.0K | $234.0K | $236.0K | $816.0K | $392.0K | $213.0K | |
| Management Fee Expense | $5.1M | $5.2M | $3.9M | $3.9M | $3.6M | $3.3M | $2.7M | $2.5M | $2.3M | $2.0M | $1.7M | $1.5M | |
| Investment Income Operating After Expense And Tax | $21.4M | $22.9M | $27.5M | $31.5M | $31.0M | $29.7M | $21.7M | $18.7M | $17.8M | $12.4M | $9.7M | $9.1M | |
| Investment Income Investment Expense | $29.7M | $30.3M | $28.4M | $34.3M | $27.2M | $26.3M | $20.1M | $18.5M | $16.2M | $10.2M | $6.8M | $5.1M | |
| Investment Company Net Expenses After Expense Support | $29.7M | $30.3M | $26.1M | $28.8M | $24.1M | $21.9M | $20.1M | $18.4M | $16.2M | $10.2M | $6.7M | $5.0M | |
| Investment Company Increase Decrease From Share Transaction | -$2.7M | -$26.0M | -$37.1M | -$2.4M | -$2.0M | $245.0M | $80.9M | $42.8M | $1.7M | $50.9M | $35.6M | $30.4M | |
| Investment Company Dividend Distribution Increase Decrease | $22.2M | $22.3M | $28.3M | $30.0M | $30.1M | $24.7M | $19.6M | $17.1M | $21.8M | $11.9M | $9.8M | $8.6M | |
| Investment Company Dividend Distribution | $22.2M | $22.3M | $28.3M | $30.0M | $30.1M | $24.7M | $19.6M | $17.1M | $21.8M | $11.9M | $9.8M | $8.6M | |
| Interest Income Operating Paid In Kind | $2.4M | $2.3M | $2.4M | $2.5M | $1.5M | $2.0M | $951.0K | $551.0K | $321.0K | $216.0K | $186.0K | $142.0K | |
| Directors Fees | $156.0K | $156.0K | $156.0K | $128.0K | $127.0K | $128.0K | $96.0K | $95.0K | $96.0K | $96.0K | $95.0K | $96.0K | |
| Administrative Fees Expense | $659.0K | $490.0K | $586.0K | $535.0K | $484.0K | $542.0K | $370.0K | $350.0K | $309.0K | $210.0K | $189.0K | $216.0K | |
| Stock Issued1 | $0.00 | $3.3M | $1.7M | $443.0K | |||||||||
| Paid In Kind Interest Noncash | $2.4M | $2.0M | $321.0K | $133.0K | |||||||||
| Interest Paid Net | $21.2M | $14.5M | $11.0M | $3.0M | |||||||||
| Amortization Of Financing Costs | $2.0M | $679.0K | $664.0K | $1.3M | $540.0K | $449.0K | $435.0K | $396.0K | $226.0K | ||||
| Stock Repurchased During Period Value | $2.7M | $26.0M | $37.1M | $5.9M | $5.1M | $0.00 | $0.00 | $0.00 | |||||
| Additional Paid In Capital | $930.6M | $933.3M | $959.3M | $1.02B | $1.02B | $1.02B | $673.9M | $593.0M | $550.3M | ||||
| Investment Owned At Fair Value | $2.01B | $2.03B | $2.12B | $2.12B | $2.11B | $2.06B | $1.85B | $1.52B | $1.39B | $1.31B |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.